These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16982409)

  • 21. Two Novel De Novo GARS Mutations Cause Early-Onset Axonal Charcot-Marie-Tooth Disease.
    Liao YC; Liu YT; Tsai PC; Chang CC; Huang YH; Soong BW; Lee YC
    PLoS One; 2015; 10(8):e0133423. PubMed ID: 26244500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT2-knockdown rescues GARS-induced Charcot-Marie-Tooth neuropathy.
    Zhao Y; Xie L; Shen C; Qi Q; Qin Y; Xing J; Zhou D; Qi Y; Yan Z; Lin X; Dai R; Lin J; Yu W
    Aging Cell; 2021 Jun; 20(6):e13391. PubMed ID: 34053152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GRS defective axonal distribution as a potential contributor to distal spinal muscular atrophy type V pathogenesis in a new model of GRS-associated neuropathy.
    Seo AJ; Park BS; Jung J
    J Chem Neuroanat; 2014 Nov; 61-62():132-9. PubMed ID: 25218976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [From gene to disease; Charcot-Marie-Tooth disease or the hereditary motor and sensory neuropathies].
    Verhamme C; Baas F
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1505-9. PubMed ID: 16032995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology.
    Grice SJ; Sleigh JN; Motley WW; Liu JL; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2015 Aug; 24(15):4397-406. PubMed ID: 25972375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.
    He W; Bai G; Zhou H; Wei N; White NM; Lauer J; Liu H; Shi Y; Dumitru CD; Lettieri K; Shubayev V; Jordanova A; Guergueltcheva V; Griffin PR; Burgess RW; Pfaff SL; Yang XL
    Nature; 2015 Oct; 526(7575):710-4. PubMed ID: 26503042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene.
    James PA; Cader MZ; Muntoni F; Childs AM; Crow YJ; Talbot K
    Neurology; 2006 Nov; 67(9):1710-2. PubMed ID: 17101916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice.
    Sleigh JN; Grice SJ; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2014 May; 23(10):2639-50. PubMed ID: 24368416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.
    Antonellis A; Ellsworth RE; Sambuughin N; Puls I; Abel A; Lee-Lin SQ; Jordanova A; Kremensky I; Christodoulou K; Middleton LT; Sivakumar K; Ionasescu V; Funalot B; Vance JM; Goldfarb LG; Fischbeck KH; Green ED
    Am J Hum Genet; 2003 May; 72(5):1293-9. PubMed ID: 12690580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V.
    Dubourg O; Azzedine H; Yaou RB; Pouget J; Barois A; Meininger V; Bouteiller D; Ruberg M; Brice A; LeGuern E
    Neurology; 2006 Jun; 66(11):1721-6. PubMed ID: 16769947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axonal Charcot-Marie-Tooth disease.
    Shy ME; Patzkó A
    Curr Opin Neurol; 2011 Oct; 24(5):475-83. PubMed ID: 21892080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathic pain model of peripheral neuropathies mediated by mutations of glycyl-tRNA synthetase.
    Lee SJ; Seo AJ; Park BS; Jo HW; Huh Y
    J Korean Med Sci; 2014 Aug; 29(8):1138-44. PubMed ID: 25120326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models.
    Morelli KH; Griffin LB; Pyne NK; Wallace LM; Fowler AM; Oprescu SN; Takase R; Wei N; Meyer-Schuman R; Mellacheruvu D; Kitzman JO; Kocen SG; Hines TJ; Spaulding EL; Lupski JR; Nesvizhskii A; Mancias P; Butler IJ; Yang XL; Hou YM; Antonellis A; Harper SQ; Burgess RW
    J Clin Invest; 2019 Dec; 129(12):5568-5583. PubMed ID: 31557132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research.
    Nave KA; Sereda MW; Ehrenreich H
    Nat Clin Pract Neurol; 2007 Aug; 3(8):453-64. PubMed ID: 17671523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charcot-Marie-Tooth disease: emerging mechanisms and therapies.
    d'Ydewalle C; Benoy V; Van Den Bosch L
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1299-304. PubMed ID: 22575637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy.
    Mo Z; Zhao X; Liu H; Hu Q; Chen XQ; Pham J; Wei N; Liu Z; Zhou J; Burgess RW; Pfaff SL; Caskey CT; Wu C; Bai G; Yang XL
    Nat Commun; 2018 Mar; 9(1):1007. PubMed ID: 29520015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.
    Banks GT; Bros-Facer V; Williams HP; Chia R; Achilli F; Bryson JB; Greensmith L; Fisher EM
    PLoS One; 2009 Jul; 4(7):e6218. PubMed ID: 19593442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies.
    Safka Brozkova D; Deconinck T; Griffin LB; Ferbert A; Haberlova J; Mazanec R; Lassuthova P; Roth C; Pilunthanakul T; Rautenstrauss B; Janecke AR; Zavadakova P; Chrast R; Rivolta C; Zuchner S; Antonellis A; Beg AA; De Jonghe P; Senderek J; Seeman P; Baets J
    Brain; 2015 Aug; 138(Pt 8):2161-72. PubMed ID: 26072516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].
    Kawakami N; Komatsu K; Yamashita H; Uemura K; Oka N; Takashima H; Takahashi R
    Rinsho Shinkeigaku; 2014; 54(11):911-5. PubMed ID: 25420567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease.
    Nan H; Takaki R; Hata T; Ichinose Y; Tsuchiya M; Koh K; Takiyama Y
    J Peripher Nerv Syst; 2019 Mar; 24(1):156-160. PubMed ID: 30394614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.